Table 1 Phenotype of patients carrying ASIP mutation

From: Aberrant expression of agouti signaling protein (ASIP) as a cause of monogenic severe childhood obesity

Patient

A (index)

B

C

D

E

Fraternal twin of E

Carrier of ASIP mutation

Yes

Yes

Yes

Yes

Yes

No

ASIP overexpression in PBLs

Yes

Yes

Yes

Not available

Yes

No

Sex

Female

Female

Female

Female

Male

Male

Age (years)

12.37

3.78

9.33

9.95

11.36

11.36

Pubertal stagea

PH4, B4

PH1, B1

PH3, B2

PH1, B1

PH2, G1

PH2, G2

Weight (kg)

156.0

25.0

60.9

60.0

89.6

62.75

Height (cm)

181.0

109.5

143.9

149.8

160.7

151.9

BMI SDS

3.75

2.65

2.83

2.40

2.89

2.22

Height SDS

3.36

1.74

0.97

1.30

1.68

0.5

Hair color

Red

Red

Reddish

Reddish brown

Brown

Brown

Hyperphagia

Moderate

Severe

Moderate

Moderate

None

None

Onset of overweight (obesity)

1st YoL (1st YoL)

2nd YoL (2nd YoL)

2nd YoL (3rd YoL)

1st YoL (2nd YoL)

1st YoL (5th YoL)

1st YoL (5th YoL)

Comorbidities

Hyperinsulinemia, impaired glucose tolerance, hepatic steatosis, hyperuricemia

Hyperuricemia

Hyperinsulinemia, impaired glucose tolerance

Hyperinsulinemia, dyslipidemia

Bronchial asthma, dyslipidemia, global developmental delay

Global developmental delay

  1. aPubertal stages indicated by B, breast stage according to Tanner; G, genital stage (male) according to Tanner; and PH, pubic hair stage according to Tanner. YoL, year of life